Outpatient Rituximab, Ifosfamide, Etoposide in DLBCL Patients >60 Years Who Are Not Candidates for HSCT
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia and Lymphoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Outpatient Rituximab, Ifosfamide, Etoposide (R-IE) in Patients Older Than 60 Years With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Who Are Not Candidates for Stem Cell Transplantation
Leukemia and Lymphoma 2019 Sep 12;[EPub Ahead of Print], M Joshi, J Taper, C Forsyth, P Rowlings, P Campbell, P Crispin, M Harvey, C Underhill, A Bayley, K Byth, G Huang, M HertzbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.